Diurexultrapdpr12
Diurex Tablet, Film Coated
Product Images NDC 52389-155
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diurex (NDC 52389-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kobayashi Healthcare International, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Diurexultraspdrug Facts
This is a description of a medication with the active ingredient caffeine anhydrous intended to relieve temporary fluid retention, abdominal bloating, swelling, and fatigue associated with menstrual and premenstrual periods. Patients should consult with a physician before use if they are taking other medications, under 18 years of age or pregnant/breastfeeding. Patients should avoid consuming too much caffeine from other sources while taking the medication as it may cause nervousness, irritability, insomnia, or occasional rapid heartbeat. Patients should stop using the medication and seek medical attention if the symptoms persist for more than ten consecutive days. The medication is recommended only for use in healthy adults and should be taken as per the instructions. The medication contains inactive ingredients such as acacia, calcium carbonate, microcrystalline cellulose, and magnesium silicate. For more information, patients can contact the number provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
